| NCT ID | NCT07162415 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tampere University Hospital |
| Condition | Wrist Ganglion |
| Study Type | INTERVENTIONAL |
| Enrollment | 220 participants |
| Start Date | 2026-01-13 |
| Primary Completion | 2034-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 220 participants in total. It began in 2026-01-13 with a primary completion date of 2034-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to learn if surgery helps with wrist ganglions in adults. The main question it aims to answer is: * Does surgery result in better patient-reported outcomes and satisfaction over a 6-months follow-up period? Researchers will compare surgery to conservative treatment (self-administered exercises and use of the hand as tolerated) to see if surgery provides superior outcomes. Participants will: * Be randomly assigned to receive either surgery or conservative treatment * Complete questionnaires about wrist pain, function, quality of life, satisfaction, and recovery at 3, 6, and 12 months
Eligibility Criteria
Inclusion Criteria: * wrist pain located in the ganglion area * diagnosis of ganglion of the wrist, based on clinical examination or imaging findings * age over 18 years * ability to fill out the Finnish or English version of the questionnaires Exclusion Criteria: * pregnant or breast feeding * other known wrist pathology that likely explains the pain * previous surgical treatments of the wrist * wrist ganglion presumed to be related to a work injury
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07162415 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Wrist Ganglion. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07162415 currently recruiting?
Yes, NCT07162415 is actively recruiting participants. Contact the research team at lasse.linnanmaki@fimnet.fi for enrollment information.
Where is the NCT07162415 trial being conducted?
This trial is being conducted at Helsinki, Finland, Jyväskylä, Finland, Tampere, Finland, Singapore, Singapore.
Who is sponsoring the NCT07162415 clinical trial?
NCT07162415 is sponsored by Tampere University Hospital. The trial plans to enroll 220 participants.